[Jin Wan Lin - Creation] Announcement: Company Receives Bid for "Whole Genome Sequencing Test Kit Reagent Set" from a National Hospital

1. Date of Fact Occurrence: 115/06/10 (Year 2026) 2. Contract or Commitment Counterparty: A National Hospital 3. Relationship with the Company: None 4. Contract or Commitment Start/End Date (or Termination Date): 115/06/10 (Year 2026) 5. Main Content (Not applicable to termination): (a) Bid Announcement Awarded Amount: NT$110,000,000 (Upper limit of the total contract amount). (b) Bid Announcement Budget Amount: NT$158,550,000. Contract Performance Start and End Dates: From June 10, 2026, to December 31, 2028. 6. Restrictive Clauses (Not applicable to termination): As per contract regulations. 7. Commitment Matters (Not applicable to termination): As per contract regulations. 8. Other Important Agreement Matters (Not applicable to termination): As per contract regulations. 9. Impact on the Company's Financials and Business: Expansion of business, increase in revenue. 10. Specific Objective: Increase operating revenue. 11. Other Matters to be Notified (If the subject of the event occurrence or resolution is a publicly issued or higher company, and this major information also meets the criteria of Article 7, Paragraph 8 of the Regulations Governing the Application of the Securities Transaction Act regarding significant impact on shareholder equity or securities prices): For financial and revenue information related to our company, please refer to the information on the Market Observation Post System. Keywords: Major Information